Urinary 11-dehydro-thromboxane B 2 and 2,3-dinor-6-keto- prostaglandin-F 1α in healthy post-menopausal and pre-menopausal women receiving aspirin 100 mg

Journal of Thrombosis and Thrombolysis

Volumn 34, Issue 1, 2012, Pages 79-84

  Hartanto, Marcia Dewi ^a   Arieselia, Zita ^b   Setiabudy, Rianto ^a   Setiawati, Arini ^a   Baziad, Ali ^a  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b Faculty of Medicine   (Indonesia)

Author keywords

11 Dehydro tromboxane B 2; 2,3 Dinor 6 keto prostaglandin F 1 ; Aspirin primary prevention; Low dose aspirin; Postmenopausal women; Thromboxane prostacyclin ratio

Indexed keywords

11 OXOTHROMBOXANE B2; 2,3 DINOR 6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLSALICYLIC ACID; PROSTACYCLIN; THROMBOXANE;

ADULT; ARTICLE; CALCULATION; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG USE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; POSTMENOPAUSE; PREMENOPAUSE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; URINALYSIS;

ADULT; ASPIRIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTMENOPAUSE; PREMENOPAUSE; PROSTAGLANDINS F; THROMBOXANE B2;

EID: 84862769034     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0689-7     Document Type: Article

References (23)

1. American Heart Association (1996) 1997 heart and stroke facts: statistical update. American Heart Association, Dallas
2. P Jousilahti E Vartiainen J Tuomilehto P Puska 1999 Sex, age, cardiovascular risk factors, and coronary heart disease a prospective follow-up: study of 14 786 middle-aged men and women in Finland Circulation 99 1165 1172 10069784 10.1161/01.CIR.99.9.1165 1:STN:280:DyaK1M7mvFSnsw%3D%3D
3. FZ Stanczyk GF Rosen EC Ditkoff AG Vijod L Bernstein RA Lobo 1995 Influence of estrogen on prostacyclin and thromboxane balance in postmenopausal women Menopause 2 3 137 144 10.1097/00042192-199502030-00005
4. A Jendryczko J Tomala 1993 An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause Zentralbl Gynakol 115 4 163 166 8503234 1:STN:280:DyaK3s3ns1Knug%3D%3D
5. AD Michelson 2004 Platelet function testing in cardiovascular diseases Circulation 110 e489 e493 15533872 10.1161/01.CIR.0000147228.29325.F9
6. Antithrombotic Trialists' Collaboration 2002 Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 71 86 10.1136/bmj.324. 7329.71
7. PM Ridker NR Cook IM Lee D Gordon JM Gaziano, et al. 2005 A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women New Engl J Med 352 13 1293 1304 15753114 10.1056/NEJMoa050613 1:CAS:528:DC%2BD2MXislCjs7Y%3D
8. L Mosca CL Banka EJ Benjamin K Berra C Bushnell, et al. 2007 Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update Circulation 115 1481 1501 17309915 10.1161/CIRCULATIONAHA.107.181546
9. DM Becker J Segal D Vaidya LR Yanek JE Herrera-Galeano PF Bray TF Moy LC Becker N Faraday 2006 Sex differences in platelet reactivity and response to low-dose aspirin therapy J Am Med Assoc 295 1420 1427 10.1001/jama.295.12.1420 1:CAS:528:DC%2BD28Xislehu74%3D
10. AC Calkin K Sudhir S Honisett MRI Williams T Dawood PA Komesaroff 2002 Rapid potentiation of endothelium-dependent vasodilation by estradiol in postmenopausal women is mediated via cyclooxygenase 2 J Clin Endocrinol Metab 87 11 5072 5075 12414874 10.1210/jc.2002-020057 1:CAS:528:DC%2BD38Xos1yntr0%3D
11. S Davison SR Davis 2003 New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy J Clin Endocrinol Metab 88 6 2470 2478 12788842 10.1210/jc.2002-021929 1:CAS:528:DC%2BD3sXkslCkur4%3D
12. M Ushioda K Makita K Takamatsu F Horiguchi D Aoki 2006 Serum lipoprotein(a) dynamics before/after menopause and long-term effects of hormone replacement therapy on lipoprotein(a) levels in middle-aged and older Japanese women Horm Metab Res 38 9 581 586 16981140 10.1055/s-2006-950504 1:CAS:528:DC%2BD28Xht1GntrvF
13. MFR Sowers KA Matthews M Jannausch JF Randolph D McConnell K Sutton-Tyrrell R Little B Lasley R Pasternak 2005 Hemostatic factors and estrogen during the menopausal transition J Clin Endocrinol Metab 90 11 5942 5948 16105968 10.1210/jc.2005-0591 1:CAS:528:DC%2BD2MXht1alt7jL
14. H Omori K Murasaki K Tanoue N Hagiwara H Kasanuki 2005 Aspirin-resistant thromboxane biosynthesis in patients with coronary artery disease; role of systemic inflammation and glycemic control J Thromb Haemost 3 1 P2224
15. JW Eikelboom J Hirsh JI Weitz M Johnston Y Qilong S Yusuf 2002 Aspirin resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, cardiovascular death in patients at high risk for cardiovascular events Circulation 105 14 1650 1655 11940542 10.1161/01.CIR.0000013777.21160.07 1:CAS:528:DC%2BD38Xjs12ns70%3D
16. A Al-Meshari MA Aleem 1995 Story of low-dose aspirin: its potential use in obstetrics by way of influencing thromboxane and prostacyclin Ann Saudi Med 15 2 103 106 17587915 1:STN:280:DC%2BD2sznt1SgsQ%3D%3D
17. IA Reilly GA FitzGerald 1987 Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs Blood J 69 180 186 1:STN:280:DyaL2s%2Fns12nuw%3D%3D
18. IA Reilly L Roy GA Fitzgerald 1986 Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon Br Med J (Clin Res Ed) 292 6527 1037 1039 10.1136/bmj.292.6527.1037 1:STN:280:DyaL287ovVKksg%3D%3D
19. A Lepäntalo J Mikkelsson JC Reséndiz L Viiri JT Backman E Kankuri PJ Karhunen R Lassila 2006 Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients Thromb Haemost 95 2 253 259 16493486
20. IAG Reilly JB Doran B Smith GA Fitzgerald 1986 Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase Circulation 73 1300 1309 2938849 10.1161/01.CIR.73.6.1300 1:STN:280: DyaL287ptVCrsw%3D%3D
21. N Chiang S Hurwitz PM Ridker CN Serhan 2006 Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A 4 formation: a randomized human trial Arterioscler Thromb Vasc Biol 26 e14 e17 16293793 10.1161/01.ATV.0000196729.98651.bf 1:CAS:528:DC%2BD28XksFOjsw%3D%3D
22. AK Pedersen 1984 Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclooxygenase New Engl J Med 311 19 1206 1211 6436696 10.1056/NEJM198411083111902 1:CAS:528:DyaL2MXhsFc%3D
23. SW Walsh 1989 Low-dose aspirin: treatment for the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia Am J Perinatol 6 2 124 132 2653334 10.1055/s-2007-999562 1:STN:280:DyaL1M3ivVaisg%3D%3D